Cerecor Inc. (NASDAQ:CERC) Files An 8-K Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition.
release announcing the Registrants financial results for the
fourth quarter and fiscal year ended December 31, 2016. A copy of
this press release is furnished herewith as Exhibit 99.1 to this
Current Report on Form 8-K and is incorporated herein by
reference.
8-K (including Exhibit 99.1) is being furnished and shall not be
deemed filed for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the Exchange Act), or otherwise
subject to the liabilities of that Section. The information in
this Current Report shall not be deemed incorporated by reference
in any filing under the Securities Act of 1933, as amended, or
the Exchange Act, except as expressly set forth by specific
reference in such a filing.
|
Exhibit No.
|
Description
|
|
|
99.1
|
Press Release, dated March 14, 2017, entitled Cerecor
Inc. Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016. |
About Cerecor Inc. (NASDAQ:CERC)
Cerecor, Inc. is a clinical stage biopharmaceutical company. The Company is engaged in developing drug candidates for patients with neurological and psychiatric disorders. The Company has a portfolio of clinical and preclinical compounds that it is developing for a range of indications, including CERC-301, which is an adjunctive treatment for major depressive disorder (MDD); CERC-501, which is for substance use disorders and adjunctive treatment of MDD, and CERC-406, which is for the treatment of cognitive impairment. The Company owns the rights to its COMTi platform. Catechol O methyltransferase (COMT) is an enzyme critical for the inactivation and metabolism of dopamine and its inhibition in the brain has applicability in treating subjects with neuropsychiatric conditions, including MDD, schizophrenia, Parkinson’s disease and pathological gambling. Its COMTi platform comprises COMT inhibitors with selectivity for membrane bound COMT, which is the dominant form of COMT. Cerecor Inc. (NASDAQ:CERC) Recent Trading Information
Cerecor Inc. (NASDAQ:CERC) closed its last trading session down -0.061 at 0.839 with 2,666,706 shares trading hands.
